Condition: Vulvovaginal Candidiasis · Sponsor: The Archer-Daniels-Midland Company
This study evaluates the effect of a multi-strain probiotic on the risk of recurrence and severity of symptoms in females with recurrent vulvovaginal candidiasis (R-VVC).
This description comes directly from the study's public registry record.
ADM Medical Team · +441460243230 · medical@protexin.com
Sanjay Dr Vaze, MBBS, MD · +9102242172325 · sanjay.v@vediclifesciences.com
Always discuss trial participation with your own doctor first.
| Anand Multispeciality Hospital | Vadodara, Gujarat, India | Recruiting |
| Life Care Hospital | Nashik, Maharashtra, India | Recruiting |
| AMF's Moraya Multispeciality Hospital | Pune, Maharashtra, India | Recruiting |
| ENT & Vertigo Clinic | Pune, Maharashtra, India | Recruiting |
| Vivaan Hospital | Sopāra, Maharashtra, India | Recruiting |
| Matritva Women's Hospital | Vasai, Maharashtra, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06480604